Form 13-F position report

REPLIMUNE GROUP INC

Reported by MORGAN STANLEY

REPL CUSIP 76029N106 Manager CIK 0000895421

Reported 1,735,654 shares, down 918,380 (34.6%) from the prior quarter.

Reported value -28.0%; share count -34.6% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q2 2024
Shares 1,735,654 Quarter-end amount reported
Reported value $15,620,886 Fair value at quarter end
Consecutive quarters held 24 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 9529000
2022-03-31 9965000
2022-06-30 10591000
2022-09-30 9645000
2022-12-31 16705043
2023-03-31 15001269
2023-06-30 15175779
2023-09-30 8030733
2023-12-31 37490132
2024-03-31 21683458
2024-06-30 15620886
2024-09-30 18520245
2024-12-31 12686767
2025-03-31 9050565
2025-06-30 8562219
2025-09-30 5763430
2025-12-31 7920720
2026-03-31 4943537
2026-06-30 7671553
2026-09-30 28305343

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for REPLIMUNE GROUP INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 2,137,865 +1,444,862 (208.5%) < 0.01% $28,305,343 2026-11-13
Q2 2026 Added 693,003 +46,790 (7.2%) < 0.01% $7,671,553 2026-08-13
Q1 2026 Reduced 646,213 -168,675 (-20.7%) < 0.01% $4,943,537 2026-05-15
Q4 2025 Reduced 814,888 -560,631 (-40.8%) < 0.01% $7,920,720 2026-02-13
Q3 2025 Added 1,375,519 +453,861 (49.2%) < 0.01% $5,763,430 2025-11-14
Q2 2025 Reduced 921,658 -6,604 (-0.7%) < 0.01% $8,562,219 2025-08-15
Q1 2025 Reduced 928,262 -119,365 (-11.4%) < 0.01% $9,050,565 2025-05-15
Q4 2024 Reduced 1,047,627 -642,176 (-38.0%) < 0.01% $12,686,767 2025-02-14
Q3 2024 Reduced 1,689,803 -45,851 (-2.6%) < 0.01% $18,520,245 2024-11-14
Q2 2024 Reduced 1,735,654 -918,380 (-34.6%) < 0.01% $15,620,886 2024-08-14
Q1 2024 Reduced 2,654,034 -1,793,194 (-40.3%) < 0.01% $21,683,458 2024-05-15
Q4 2023 Added 4,447,228 +3,977,869 (847.5%) < 0.01% $37,490,132 2024-02-13
Q3 2023 Reduced 469,359 -184,206 (-28.2%) < 0.01% $8,030,733 2023-11-15
Q2 2023 Reduced 653,565 -195,884 (-23.1%) < 0.01% $15,175,779 2023-08-14
Q1 2023 Added 849,449 +235,293 (38.3%) < 0.01% $15,001,269 2023-05-15
Q4 2022 Added 614,156 +55,760 (10.0%) < 0.01% $16,705,043 2023-02-14
Q3 2022 Reduced 558,396 -47,423 (-7.8%) < 0.01% $9,645,000 2022-11-14
Q2 2022 Added 605,819 +18,972 (3.2%) < 0.01% $10,591,000 2022-08-15
Q1 2022 Added 586,847 +235,226 (66.9%) < 0.01% $9,965,000 2022-05-13
Q4 2021 Reduced 351,621 -6,808 (-1.9%) < 0.01% $9,529,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

176 managers reported REPLIMUNE GROUP INC for Q2 2024.

Managers reporting REPLIMUNE GROUP INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BAKER BROS ADVISORS LP Added 10,045,336 +500,000 1.16% $90,408,024 17 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 9,236,057 +2,687,127 < 0.01% $83,126,000 17 qtrs
Redmile Group LLC Added 5,562,096 +1,832,113 3.03% $50,058,864 24 qtrs
FCPM III SERVICES B V Unchanged 4,866,449 0 6.46% $43,798,041 3 qtrs
BlackRock Inc Added 4,713,791 +101,233 < 0.01% $42,424,119 24 qtrs
MILLENNIUM MANAGEMENT LLC Added 3,118,035 +2,656,173 0.01% $28,062,315 19 qtrs
VANGUARD GROUP INC Added 2,895,114 +124,786 < 0.01% $26,056,026 24 qtrs
Omega Fund Management LLC Reduced 2,461,319 -540,000 16.41% $22,151,871 24 qtrs
Atlas Venture Life Science Advisors LLC Unchanged 2,098,300 0 1.99% $18,884,700 11 qtrs
MORGAN STANLEY This report Reduced 1,735,654 -918,380 < 0.01% $15,620,886 24 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 14, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,728,588
Shared
907
None
6,159

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.